The word is chutzpa – and it’s hard to imagine a better way to describe UC Berkeley (UCB) Vice Provost Sheldon Zedeck’s assignment of Arthur Reingold to investigate misconduct allegations against Professor Peter Duesberg, PhD. The charges stem from Duesberg’s (et al) report that was published in 2009 by Medical Hypotheses. Citing 35 references that includes South Africa’s (SA) own mortality reports, Prof. Duesberg’s team concluded that:
…huge losses of African lives are unconfirmed and that HIV is not sufficient or even necessary to cause the previously known diseases, now called AIDS in the presence of antibody against HIV. Further we call into question the claim that HIV antibody-positives would benefit from anti-HIV drugs, because these drugs are inevitably toxic and because there is as yet no proof that HIV causes AIDS.
If AIDS allegedly kills millions in Africa, why has Africa’s population doubled from 400-800 million during the same period?
Not since the trials of Galileo and Ignaz Semmelweis has a scientist been more of a threat to a corrupt scientific establishment. Considered one of the world’s most eminent cancer researchers, Prof. Duesberg’s 1987 paper sent shockwaves through research facilities, universities and HHS. Like Galileo’s exposure of Pope Urban’s geocentric universe, Prof. Duesberg’s unanswered questions implicated thousands of scientists and jeopardized billions of dollars in research funding.
As OMSJ described last week, AIDS Inc. is currently threatened on numerous fronts. While Celia Farber’s libel lawsuit against Treatment Action Group (TAG) makes its way through the New York Supreme Court, trial attorneys in more than thirty criminal HIV cases are forcing prosecutors to locate AIDS experts who are willing to testify under penalty of perjury. Unsurprisingly, the industry that has spent $7 billion to settle dozens of criminal and civil complaints since 2004 are responding like vampires in sunshine.
The Case Against Professor Duesberg
According to Science Insider, the UCB investigation is based upon complaints from none other than Nathan Geffen of the Treatment Action Campaign (TAC), which is funded by mining giant AngloGold and TAG, which is funded by pharma.
Geffen’s complaint exploits an insignificant error related to reported HIV prevalence within prenatal clinics. Because the error does not alter the paper’s conclusions, Geffen’s anxiety apparently stems from being caught manipulating computer models to exaggerate AIDS mortality…
Geffen relies on a report by Pride Chigwedere MD (et al), in which Chigwedere admits to using estimates that UNAIDS admits were deliberately inflated. Chigwedere’s report was funded by the Harvard School of Public Health, which received a $160 million spike of AIDS funding from HRSA in the years leading up to publication (2008).
… while SA’s actual mortality represents a tiny fraction of Geffen’s inflated numbers:
By 2007, reported HIV mortality remained negligible:
Without Geffen’s propaganda, AngloGold could not blame its mine-related lung diseases on the sexual stereotypes of its kaffir labor force; groups like TAG and TAC could not use the nonexistent pandemic to fund gay pharmaceutical activism and universities like Berkeley and Harvard could not justify the continued research of what prosecutors are finally dismissing as junk science.
Epidemiologists Without a Cause
Because infectious disease became statistically inconsequential in the US by 1955, epidemiologists suddenly found themselves with a lot of free time.
Even at the height of the alleged pandemic, AIDS mortality affected no more than .015 percent of the US population:
Because researchers throughout Europe (2), Australia and South Africa  have corroborated these numbers, UCB and Reingold rely on reports like Geffen’s to justify continued NIH (taxpayer) funding.
In light of the pharmaceutical industry’s routine corruption, Geffen’s cynical complaint isn’t worth the paper it’s written on.
Conflicts of Interest
Geffen also alleges that co-author David Rasnick PhD should have reported his brief association with health advocate Matthias Rath MD. To assert that a co-author’s relationship (that ended is 2006) represents a punishable conflict of interest against Duesberg is absurd – especially when considering the breathtaking conflicts of his accusers and employer.
Since 1992, the NIH has directed to UC Berkeley approximately $200 million in AIDS-related funding. A glance at 2010 indicates what is at stake:
In light of these facts, it’s understandable why, like Robert Gallo, Vice Provost Zedeck has avoided thousands of highly qualified licensed investigators to assign the only man with reason to obfuscate the obvious to convict America’s resident Galileo.
A Call for Action
A few years ago, Professor Duesberg would be forced to defend himself from Berkeley’s kangaroo court. Today, OMSJ is assisting Prof. Duesberg and thousands of other victims of medical and scientific corruption.
But OMSJ cannot succeed alone. With your generous single or recurring donation of $5, $10/mo or more, you can help OMSJ assist Professor Duesberg and other victims.
UPDATE May 28 2010 – Berkeley dismisses misconduct charges against Prof. Duesberg
More from my site
Tags: AIDS, AngloGold, Arthur Reingold, Galileo, HIV, Ignaz Semmelweis, Medical Hypotheses, mortality, Nathan Geffen, NIH, Peter Duesberg, Pope Urban, Science Insider, Sheldon Zedeck, South Africa, Treatment Action Campaign, Treatment Action Group